Globally, more than 5 million people die from lack of access to treatments for kidney disease each year — and it's projected to become the fifth leading cause of death worldwide by 2040.
According to the World Health Organization, the main noncommunicable diseases include cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. But current efforts to tackle NCDs often fail to address chronic kidney disease — a vastly underdiagnosed, progressive NCD frequently caused by diabetes, hypertension, or obesity.
This event produced by Devex in collaboration with AstraZeneca and funded by AstraZeneca on the occasion of the 78th session of the U.N. General Assembly will explore the urgent need for improving access to and funding for the prevention and screening of chronic kidney disease. It will also discuss how diagnosing the disease before it advances can create significant impact at a societal level, not least on the environment. During the event, we’ll present findings from a new study demonstrating the broad ranging impact of CKD across health care systems, societies, and the environment.
So what are the current barriers to diagnostics for CKDs and how can health systems adopt a more holistic approach to NCD care and management?
We’ll bring together industry experts and leading global stakeholders to address kidney health within the broader UHC agenda, alongside NCDs such as diabetes, hypertension, and obesity, making it central to health policy.
Join us in New York or online as we bring new considerations to the debate around NCD care.
The event will be followed by a networking lunch for in-person attendees.
Registration & coffee
•Richard Jones, editorial director, Devex
Fireside chat – The burden of CKD: New data, new insights
• Marisol Robles, president, Mario Robles Ossio Foundation
• Professor Alistair McGuire, head of department of Health Policy, professor of health economics, London School of Economics
Interviewed by: Richard Jones, editorial director, Devex
Panel: How good kidney health for all can transform chronic disease management and strengthen UHC
• Dr. Jeff Markuns, regional president for North America, World Organization of Family Doctors
• Dr. Slim Slama, Unit head, noncommunicable diseases management-screening, diagnosis and treatment (MND), NCD Department, World Health Organization
• Katie Dain, Chief executive officer, NCD Alliance
• Dr. Sonia Browne, Minister of state in the Ministry of Health and Wellness, Barbados
Interviewed by: Jenny Lei Ravelo, Senior reporter, Devex
Firestarter: Dr. Anselm Hennis, Director of the department of noncommunicable diseases and mental health, Pan American Health Organization
• Dr. Adeera Levin, professor of medicine and consultant nephrologist at the University of British Columbia, and past-president of the International Society of Nephrology
• Joris Silon, U.S. country president, bioPharmaceuticals business unit, Astrazeneca
In-person networking lunch hosted by AstraZeneca